| 1 |
Partly verified |
Full text not readStored summary read |
N01 · Evidence conditionWhat are the selected subclaim and the question and record pointers?Required |
The selected stored summary concerns pain improvement and distinguishes the selected claim from its verdict record. Other native records and the original parent context are preserved without creating a new main record, split or certification of independence. |
Some original-summary information was linked for preparation; clinical verification and review are not complete. The selected source wording, question and record pointers, and parent and sibling context. This scope remains for user review. |
The selected source wording, question and record pointers, and parent and sibling context. |
If the original question or materials change, record the distinction between the existing scope and a separate question. |
| 2 |
Partly verified |
Full text not readStored summary read |
N02 · Evidence conditionHow are the subclaim's actual grade and note, and absent score, status and axes, retained?Required |
The selected subclaim's grade B and note 'Positive in one small trial.' are retained. score, status and axes are absent from the original subclaim record; null and field absence are recorded. The parent's grade C, 50 points and axes are separate context. |
Some original-summary information was linked for preparation; clinical verification and review are not complete. The selected subclaim's actual fields and the parent's separate actual values. This scope remains for user review. |
The selected subclaim's actual fields and the parent's separate actual values. |
If the subclaim is corrected, retain the full original text before the change and a record of the correction event. |
| 3 |
Partly verified |
Full text not readStored summary read |
N03 · Evidence conditionWhat are the parent assessment, axes, safety label, null, false and empty values?Required |
The parent's grade C, 50 points, B/P/R1/I1/E+/B2 and safety label Caution are retained. precision remains null; coprimary_split, big_hard_rct and no_human_study remain false; override_reason and override_reason_en remain empty strings. The original parent assessment and cross-checking narrative are not a new review or subclaim assessment. |
Some original-summary information was linked for preparation; clinical verification and review are not complete. The parent assessment, axes, original evaluation, history and limits of applicability. This scope remains for user review. |
The parent assessment, axes, original evaluation, history and limits of applicability. |
If separate correction materials arrive, distinguish the original values, reasons for changes and correction events. |
| 4 |
Partly verified |
Full text not readStored summary read |
N04 · Evidence conditionHow are KO/EN text, dates, corrections and empty values preserved?Required |
The parent's and subclaim's KO/EN text, verified_date 2026-08-26, the empty corrections array and the empty deliberation string are retained. The stored summary's historical evaluation is distinguished from the current preparation time. |
Some original-summary information was linked for preparation; clinical verification and review are not complete. The actual versions of each language's original text, evidence date, corrections and history. This scope remains for user review. |
The actual versions of each language's original text, evidence date, corrections and history. |
Record a new correction as a separate event with the full original text before the change, version and reason. |
| 5 |
Partly verified |
Full text not readStored summary read |
N05 · Evidence conditionWhat was actually read, and which external materials remain unread?Required |
The stored existing review summary was read. External abstracts, full papers, registrations, plans, SAPs, results and safety tables were not accessed. Earlier assessments and citations in the stored summary do not mean external materials were read or reviewed in this work. |
Some original-summary information was linked for preparation; clinical verification and review are not complete. Acquisition and reading scope for each material, and the locations of original results. This scope remains for user review. |
Acquisition and reading scope for each material, and the locations of original results. |
If additional materials are read directly in a separate step, record the actual extent, scope, version and time. |
| 6 |
Partly verified |
Full text not readStored summary read |
N06 · Evidence conditionWhat are the identity, year and bibliographic details of the primary report?Required |
The primary report is the Garfinkel et al. 1998 randomized trial, JAMA 1998;280:1601-1603, PMID 9820263. The DOI, PMCID and detailed identity of the external full paper remain unverified. |
Some original-summary information was linked for preparation; clinical verification and review are not complete. Original bibliographic details and materials linking the paper to the trial and population. This scope remains for user review. |
Original bibliographic details and materials linking the paper to the trial and population. |
First establish whether a new report concerns the same trial and population or a different trial. |
| 7 |
Partly verified |
Full text not readStored summary read |
N07 · Evidence conditionHow is the sharing of one report, population and outcomes across the two tables shown?Required |
Grip strength and pain are two stored questions from the same 1998 eight-week report and population. Phalen, sleep, Tinel, nerve conduction, the sibling table and parent context are not added as separate independent trials or participants. |
Some original-summary information was linked for preparation; clinical verification and review are not complete. Overlap information for reports, trials, people, wrists, groups, outcomes and time points. This scope remains for user review. |
Overlap information for reports, trials, people, wrists, groups, outcomes and time points. |
When follow-up or companion reports are added, distinguish a shared population from independent data. |
| 8 |
Partly verified |
Full text not readStored summary read |
N08 · Evidence conditionWhat population and eligibility criteria were used for carpal tunnel syndrome?Required |
The question concerns carpal tunnel syndrome. Detailed diagnostic criteria, age, severity, wrist-specific status and inclusion and exclusion criteria are absent from the current summary, so the findings are not extended to all patients or all wrist pain. |
Some original-summary information was linked for preparation; clinical verification and review are not complete. Original information on diagnosis, recruitment, inclusion, exclusion, severity and baseline function. This scope remains for user review. |
Original information on diagnosis, recruitment, inclusion, exclusion, severity and baseline function. |
Application to other populations or severity levels requires direct comparative data for those populations. |
| 9 |
Unverified |
Full text not readStored summary read |
N09 · Evidence conditionHow much is known about baseline risk, representativeness and everyday exposure?Supplementary; required for general application |
Baseline characteristics by group, occupation and repetitive use, comorbidities, concurrent treatments, baseline tests and recruitment setting remain unverified. A population label alone does not establish individual response or suitability for the intervention. |
Required direct details remain unverified within the current summary and unread external materials. Original information on baseline characteristics, group distributions, recruitment and concurrent exposures. This scope remains for user review. |
Original information on baseline characteristics, group distributions, recruitment and concurrent exposures. |
General application should be distinguished using data showing differences in the actual population and setting. |
| 10 |
Partly verified |
Full text not readStored summary read |
N10 · Evidence conditionWhat upper-body yoga program was used in the original study?Required |
The original intervention was eight weeks of yoga with 11 postures for strengthening, stretching and balancing upper-body joints, plus relaxation. These are the study conditions of a specific supervised program, not all yoga or stretching. No new instructions on posture, intensity, breathing or timing are provided. |
Some original-summary information was linked for preparation; clinical verification and review are not complete. Original information on the supervised program's identity, delivery, actual exposure, instructors and modifications. This scope remains for user review. |
Original information on the supervised program's identity, delivery, actual exposure, instructors and modifications. |
Differences between programs should be distinguished using direct comparative data. |
| 11 |
Partly verified |
Full text not readStored summary read |
N11 · Evidence conditionWhat were the original comparison conditions for the wrist-splint active control?Required |
The original comparator was a wrist splint. The trial used an active control only; wait-list or attention controls are not presented as groups that were actually used. Details of splint type, timing, actual use, instruction, expectations and differences in care remain unverified. |
Some original-summary information was linked for preparation; clinical verification and review are not complete. Original information on the splint control's delivery, exposure, attention, adherence and concurrent care. This scope remains for user review. |
Original information on the splint control's delivery, exposure, attention, adherence and concurrent care. |
Link other control conditions only after distinguishing whether they were actually used and for what purpose. |
| 12 |
Unverified |
Full text not readStored summary read |
N12 · Evidence conditionWhat are the details of actual program exposure, adherence, discontinuation and concurrent treatment?Required |
The eight-week duration and program components are recorded, but actual attendance, frequency, cumulative exposure, practice, splint adherence, concurrent medicines or procedures, discontinuation and modifications remain unverified. Complete individual adherence to the original program is not assumed. |
Required direct details remain unverified within the current summary and unread external materials. Group-specific records of actual exposure, adherence, modifications, concurrent treatment and discontinuation. This scope remains for user review. |
Group-specific records of actual exposure, adherence, modifications, concurrent treatment and discontinuation. |
Direct data distinguishing the assigned program from actual adherence are needed. |
| 13 |
Partly verified |
Full text not readStored summary read |
N13 · Evidence conditionHow much is known about the randomized single-blind design and allocation procedures?Required |
The recorded design is a randomized single-blind active-control trial. External details of sequence generation, concealment, baseline balance between groups and allocation implementation have not been read. The design label alone does not certify adequacy. |
Some original-summary information was linked for preparation; clinical verification and review are not complete. Original plans and reports on sequence generation, allocation concealment, implementation and baseline balance. This scope remains for user review. |
Original plans and reports on sequence generation, allocation concealment, implementation and baseline balance. |
When allocation materials are added, distinguish what is known from what remains unverified. |
| 14 |
Partly verified |
Full text not readStored summary read |
N14 · Evidence conditionIs assessor blinding the same as blinding of pain responses and awareness of the intervention?Required |
The original account states that one physician, unaware of allocation, performed assessments. Details of participant and instructor blinding, pain responses, measurement procedures and differences in expectations remain unverified. Assessor blinding is not extended to every person or outcome. |
Some original-summary information was linked for preparation; clinical verification and review are not complete. Original information on assessors, respondents, intervention awareness, tests, expectations and measurement procedures. This scope remains for user review. |
Original information on assessors, respondents, intervention awareness, tests, expectations and measurement procedures. |
Measurement, response and blinding data are needed for each outcome. |
| 15 |
Partly verified |
Full text not readStored summary read |
N15 · Evidence conditionWhat were the original denominators for randomization, analysis and exclusions or withdrawals?Required |
The original numbers are retained: 51 randomized, 42 analyzed and 9 withdrawn or excluded. Allocation, completion and reasons for exclusion by group, and the actual denominators for grip strength and pain, remain unverified. No new attrition rates or group counts are calculated. |
Some original-summary information was linked for preparation; clinical verification and review are not complete. Group-specific flow diagrams, inclusion and exclusion information, outcome denominators and missing data. This scope remains for user review. |
Group-specific flow diagrams, inclusion and exclusion information, outcome denominators and missing data. |
Original materials explaining the actual analysis population for each outcome are needed. |
| 16 |
Partly verified |
Full text not readStored summary read |
N16 · Evidence conditionWhat are the gaps in completer analysis, missing data and sensitivity analyses?Required |
The original limitation of analysis of 42 completers is retained. Outcomes for all randomized participants, missing data by group, exclusion reasons, imputation and sensitivity analyses remain unverified. The 9 original exclusions are not converted into 9 clinical adverse events. |
Some original-summary information was linked for preparation; clinical verification and review are not complete. Definitions of completer and full analyses, group-specific missing data, reasons, handling and sensitivity analyses. This scope remains for user review. |
Definitions of completer and full analyses, group-specific missing data, reasons, handling and sensitivity analyses. |
Direct analysis materials addressing the effect of missing data after allocation are needed. |
| 17 |
Partly verified |
Full text not readStored summary read |
N17 · Evidence conditionHow are eight-week results distinguished from persistence after treatment ends?Required |
The original selected outcomes are grip strength and pain in an eight-week trial. Direct figures for persistence after treatment, recurrence and long-term function are absent from the current summary, so the findings are not extended to long-term treatment effects. |
Some original-summary information was linked for preparation; clinical verification and review are not complete. Direct information on the starting point, measurement schedule, follow-up, treatment changes and long-term tracking. This scope remains for user review. |
Direct information on the starting point, measurement schedule, follow-up, treatment changes and long-term tracking. |
Persistent outcomes require adequate follow-up and direct comparative data. |
| 18 |
Unverified |
Full text not readStored summary read |
N18 · Evidence conditionWhat are the outcome hierarchy and multiplicity for grip, pain, other symptoms and tests?Required |
The recorded endpoints are eight-week grip strength and pain, plus several symptoms and tests. The precise primary, secondary and exploratory hierarchy, prespecified plans, multiplicity and analysis versions remain unverified. The selected subclaim questions are not newly certified as individually registered primary outcomes. |
Required direct details remain unverified within the current summary and unread external materials. Original protocols, plans, outcome hierarchy, multiplicity and analysis materials. This scope remains for user review. |
Original protocols, plans, outcome hierarchy, multiplicity and analysis materials. |
Direct materials distinguishing prespecified plans from actual reporting for each outcome are needed. |
| 19 |
Unverified |
Full text not readStored summary read |
N19 · Evidence conditionHow does the historical registration statement differ from actual registration verification?Required |
The original nct string states 'Not present because the study predates trial registration.' It is retained as a historical status statement, not a valid registration number. No registration search or access was performed in this work, and absence from every registration system is not newly certified. |
Required direct details remain unverified within the current summary and unread external materials. Original public materials on contemporaneous plans, registration status and analysis documents. This scope remains for user review. |
Original public materials on contemporaneous plans, registration status and analysis documents. |
When planning materials are added, record the relationship between that version and the report. |
| 20 |
Partly verified |
Full text not readStored summary read |
N20 · Evidence conditionWhat is the original scope of 'independent funding not established'?Required |
The funding record states that independent funding was not established; the earlier assessment says the stored summary's Funding statement was not obtained. This does not establish no sponsorship, public funding or corporate funding, and is not current external verification. |
Some original-summary information was linked for preparation; clinical verification and review are not complete. Original disclosures on sponsorship, funding and provision of products or facilities. This scope remains for user review. |
Original disclosures on sponsorship, funding and provision of products or facilities. |
When sponsorship disclosures are added, distinguish the original unverified status from the new-information event. |
| 21 |
Unverified |
Full text not readStored summary read |
N21 · Evidence conditionWhat interests and research roles did authors, instructors and institutions have?Required |
Details of contracts, author-specific interests, program provision, data access, design, analysis and publication roles remain unverified. Failure to establish these details is not filled in as absence of interests. |
Required direct details remain unverified within the current summary and unread external materials. Public information on conflicts of interest, sponsorship, program provision, data access, analysis and publication roles. This scope remains for user review. |
Public information on conflicts of interest, sponsorship, program provision, data access, analysis and publication roles. |
Independence should be distinguished using materials showing the actual parties, involvement and data sharing. |
| 22 |
Unverified |
Full text not readStored summary read |
N22 · Evidence conditionHow much harm data were actually collected and reported for yoga and splints?Required |
The original safety label is Caution; the parent safety narrative is retained as a historical stored summary. Direct study-specific tables of adverse-event counts, definitions, collection, severity, group denominators and follow-up are unavailable here. No new advice on stopping, treatment or self-care is given to individuals. |
Required direct details remain unverified within the current summary and unread external materials. Original safety-collection methods, events, group denominators, exposure, duration and discontinuation data. This scope remains for user review. |
Original safety-collection methods, events, group denominators, exposure, duration and discontinuation data. |
Harms from exercise and control exposures require direct event-specific verification and comparative data. |
| 23 |
Unverified |
Full text not readStored summary read |
N23 · Evidence conditionWhat are the timing, changes, missing data and alternative explanations for harms?Required |
The temporal relationships of actual movements, splint use, baseline severity, concurrent treatments and discontinuation with symptoms or harms remain unverified. The 9 withdrawals or exclusions are not assumed to be harms, and a single cause is not established. |
Required direct details remain unverified within the current summary and unread external materials. Baseline risk, actual exposure, changes, event timing, verification, missing data and reasons for discontinuation. This scope remains for user review. |
Baseline risk, actual exposure, changes, event timing, verification, missing data and reasons for discontinuation. |
Interpretation of harms should be supplemented by data on actual exposure, verification, comparisons and alternative explanations. |
| 24 |
Unverified |
Full text not readStored summary read |
N24 · Evidence conditionWhat are the gaps in long-term harms, vulnerable populations and rare harms?Supplementary; required for extending safety conclusions |
A summary of a small selected population over eight weeks cannot establish long-term or rare harms, or safety at other severity levels or with comorbidities. The original Caution label and unverified direct safety data are retained. |
Required direct details remain unverified within the current summary and unread external materials. Long-term follow-up and exposure, denominator and comparative data for vulnerable populations and rare events. This scope remains for user review. |
Long-term follow-up and exposure, denominator and comparative data for vulnerable populations and rare events. |
Long-term and rare harms require separate direct data with adequate follow-up and collection. |
| 25 |
Partly verified |
Full text not readStored summary read |
N25 · Evidence conditionCan harm and symptom outcomes from the same trial be counted as independent replication?Required |
Grip, pain, signs, tests, the parent safety narrative and the two tables from one trial share the same report and population. Multiple outcomes do not create independent replications of effects or harms. |
Some original-summary information was linked for preparation; clinical verification and review are not complete. Relationships between reports, trials, populations, outcomes and follow-up, and the identity of new materials. This scope remains for user review. |
Relationships between reports, trials, populations, outcomes and follow-up, and the identity of new materials. |
First distinguish whether new materials concern the same population or an independent one, then link them. |
| 26 |
Partly verified |
Full text not readStored summary read |
N26 · Evidence conditionWhat are the direction, range and units of the pain scale?Required |
The original description says that higher pain values indicate more pain and that the yoga group decreased from 5.0 to 2.9. The instrument name, minimum and maximum scale values, units and reference period remain unverified. Do not assume a 0–10 scale or another scale. |
Some information from the original summary was linked during preparation; clinical verification and review are not complete. The scope of original materials on the pain instrument, scale range, units, response period and collection procedure remains subject to user review. |
Original materials on the pain instrument, scale range, units, response period and collection procedure. |
Direct materials giving the precise measurement definition of pain are needed. |
| 27 |
Partly verified |
Full text not readStored summary read |
N27 · Evidence conditionWhat kind of values are the original numbers 5.0 and 2.9?Required |
The English product_facts states that the yoga group's mean decreased from 5.0 to 2.9. The original before-and-after values are preserved; splint-group values, variability, actual group denominators, between-group estimates, CI, P values and adjustment details remain unverified. |
Some information from the original summary was linked during preparation; clinical verification and review are not complete. The scope of group-specific baseline and 8-week values, variability, denominators, original analyses, intervals and the definition of the mean remains subject to user review. |
Group-specific baseline and 8-week values, variability, denominators, original analyses, intervals and the definition of the mean. |
Materials directly showing the actual comparator and effect of interest are needed. |
| 28 |
Unverified |
Full text not readStored summary read |
N28 · Evidence conditionIs within-group pain change the same as the between-group effect versus splinting?Required |
The parent and subclaim describe a positive pain outcome, but the current numbers 5.0→2.9 refer to the yoga group's mean before and after treatment. Do not present them as a new between-group difference, adjusted effect or relative reduction. |
The necessary direct details remain unverified within the current summary and unread external materials. The scope of original yoga-versus-splint comparisons and analyses of within-group and between-group effects, adjustments, time points and denominators remains subject to user review. |
Original yoga-versus-splint comparisons and analyses of within-group and between-group effects, adjustments, time points and denominators. |
An intervention's comparative effect must be answered with the actual comparator and between-group analysis materials. |
| 29 |
Unverified |
Full text not readStored summary read |
N29 · Evidence conditionAre clinically meaningful pain thresholds, responders and durability verified?Required |
There are currently no direct values for meaningful pain-change thresholds, responders, distributions, daily function, long-term durability or recurrence. Do not extend a lower mean to treatment for every patient, nerve recovery or long-term elimination of pain. |
The necessary direct details remain unverified within the current summary and unread external materials. The scope of direct materials on responders, meaningful change, function, distributions and long-term follow-up remains subject to user review. |
Direct materials on responders, meaningful change, function, distributions and long-term follow-up. |
Patient-perceived response and durability require direct materials for the relevant outcome and period. |
| 30 |
Unverified |
Full text not readStored summary read |
N30 · Evidence conditionWhat are the details of pain responses, blinding, expectations and concurrent treatment?Required |
The original information mentions assessment by a single physician unaware of allocation, but details of pain respondents, instruments, expectations, instructional attention, analgesics, concurrent treatment, collection and missing data remain unverified. Do not turn assessor blinding into an absence of all bias in pain reporting. |
The necessary direct details remain unverified within the current summary and unread external materials. The scope of original materials on pain responses, blinding, expectations, concurrent management, collection and missing data remains subject to user review. |
Original materials on pain responses, blinding, expectations, concurrent management, collection and missing data. |
The pain effect of interest requires actual measurement, comparator and concurrent-management materials. |
| 31 |
Partly verified |
Full text not readStored summary read |
N31 · Evidence conditionDoes pain substitute for grip strength, Phalen's sign, sleep, Tinel's sign or nerve conduction?Required |
Grip strength of 162→187 mmHg and some improvement in Phalen's sign are other outcomes. The original descriptions of no effect on sleep, Tinel's sign and nerve-conduction testing are preserved. Do not transfer pain improvement to improvement in these outcomes or recovery of nerve conduction. |
Some information from the original summary was linked during preparation; clinical verification and review are not complete. The scope of definitions, time points, denominators, hierarchy, between-group estimates and original tables for each outcome remains subject to user review. |
Definitions, time points, denominators, hierarchy, between-group estimates and original tables for each outcome. |
Other symptoms and tests need materials that directly answer their own questions. |
| 32 |
Partly verified |
Full text not readStored summary read |
N32 · Evidence conditionWhat historical scope underlies the lack of confirmatory replication and the 28-year statement?Required |
The original explanation describes no confirmatory replication after the 1998 trial, and the synthesis says that independent replication had not been verified 28 years later. This is preserved only as history at the original cut-off; no new search or current certification of independence was performed. |
Some information from the original summary was linked during preparation; clinical verification and review are not complete. The scope of new bibliographic, population, intervention, comparator and direct-outcome materials for the same pain question remains subject to user review. |
New bibliographic, population, intervention, comparator and direct-outcome materials for the same pain question. |
When additional results emerge, distinguish their relationships with the same report and population from independent materials. |
| 33 |
Unverified |
Full text not readStored summary read |
N33 · Evidence conditionCan the finding be extended to general yoga, long-term treatment or other pain conditions?Supplementary; required for extending applicability |
The current scope is an 8-week preliminary comparison of a specific instructed program versus splinting for carpal tunnel syndrome. Direct pain outcomes for general yoga, other programs, severity levels, causes and long-term treatment effects remain unverified. |
The necessary direct details remain unverified within the current summary and unread external materials. The scope of direct materials showing differences in diagnosis, program, comparator and duration remains subject to user review. |
Direct materials showing differences in diagnosis, program, comparator and duration. |
Pain effects under other conditions must be distinguished using the relevant question, comparator and actual exposure materials. |
| 34 |
Partly verified |
Full text not readStored summary read |
N34 · Evidence conditionHow are the original pain direction, subclaim grade B and parent limitations preserved together?Required |
The subclaim's grade B and note of a positive outcome in a small trial are preserved unchanged. The parent grade C50 history of completers, small size, 8 weeks, some positive outcomes and no replication is preserved alongside them. Do not assign the parent's grade to the subclaim or delete the positive pain outcome. |
Some information from the original summary was linked during preparation; clinical verification and review are not complete. The scope of original subclaim and parent texts, direct pain analyses and uncertainty materials remains subject to user review. |
Original subclaim and parent texts, direct pain analyses and uncertainty materials. |
Material updates must distinguish the original verdict and observations from the new preparation status. |
| 35 |
Partly verified |
Full text not readStored summary read |
N35 · Evidence conditionWhat records are kept when pain materials or corrections are updated?Required (update boundaries) |
Keep the original pain numbers, direction, language, dates, empty correction fields and the shared report relationship with the grip-strength sheet. For new materials, distinguish the full stored summary before modification, version and reasons from condition changes and events applying separate observations. |
Some original-summary information was linked for preparation; clinical verification and review are not complete. Original locations, versions, questions, conditions, reasons for observation changes and additional direct materials. This scope remains for user review. |
Original locations, versions, questions, conditions, reasons for observation changes and additional direct materials. |
If new original materials are separately added, link them to the relevant item while retaining the user's review scope. |